Skip to Content

Most Recent

  • Article
  • Open Access

A Single C226S Mutation Rescues Fragmentation and Enhances Antigen-Binding Activity of a Giant Panda Chimeric Antibody Against Canine Distemper Virus

  • Yunli Li,
  • Qiaoli Lang,
  • Jianhong Zeng,
  • Wei Wang and ,
  • Hongwen Zhang,
  • Dongsheng Zhang,
  • Xia Yan,
  • Xiaoyan Su,
  • Chanjuan Yue and
  • Songrui Liu
  • + 6 authors+ 1 author

4 November 2026

Background/Objectives: Canine distemper virus (CDV) poses a major threat to the conservation of the endangered giant panda (Ailuropoda melanoleuca). Although monoclonal antibodies hold great therapeutic promise, the development of species-specific an...

(This article belongs to the Section Antibody Discovery and Engineering)
  • Article
  • Open Access

Rubella Antibody Prevalence Among Women of Reproductive Age in Croatia: Implications for the Prevention of Congenital Rubella Syndrome

  • Tatjana Vilibić-Čavlek,
  • Klara Barbić,
  • Maja Bogdanić,
  • Vesna Višekruna Vučina and ,
  • Dan Navolan,
  • Flavius Olaru,
  • Adrian Ratiu and
  • Bernard Kaić
  • + 3 authors+ 0 author

3 November 2026

Background/Objectives: Rubella immunity in childbearing-aged women is crucial due to the risk of congenital rubella syndrome (CRS). This study analyzed temporal trends in rubella virus (RUBV) seroprevalence among women of reproductive age in Croatia....

(This article belongs to the Section Humoral Immunity)
  • Review
  • Open Access
2 Views
14 Pages

Functional Human Humoral Immunity in Humanized Mice: A Spatiotemporal Framework

  • Yoshie Kametani,
  • Yusuke Ohno,
  • Ryoji Ito,
  • Sunao Shoji and
  • Takashi Shiina

2 November 2026

Functional human humoral immunity remains one of the greatest challenges in humanized mouse research. Although numerous humanized mouse models have been developed, reproducing efficient antigen-specific antibody responses remains difficult. This revi...

(This article belongs to the Section Humoral Immunity)
  • Article
  • Open Access
111 Views
16 Pages

30 October 2026

Background/Objectives: Histological examination with hematoxylin and eosin staining (H&E) is commonly used in dermatology, although for autoimmune blistering diseases (AIBD) direct immunofluorescence (DIF) is considered “the gold standard&r...

(This article belongs to the Special Issue Immune Phenomena in Autoimmune Skin Disorders)
  • Article
  • Open Access
137 Views
24 Pages

Engineering a Trispecific EGFR × c-MET × VEGF Antibody with Multiple Mechanisms of Action for Antitumor Activity in Gastrointestinal Cancer Models

  • Hao Jiang,
  • Ying Jin,
  • Yuqiang Xu,
  • Peng Chen and ,
  • Simin Wu,
  • Zhengxia Zha,
  • Meixia Fu,
  • Guangmao Mu,
  • Bin Ma and
  • Mark L. Chiu
  • + 10 authors+ 5 authors

29 October 2026

Background: A leading cause of cancer-related mortality worldwide, gastrointestinal (GI) cancers are often recalcitrant to single agent therapies. Dysregulations of the EGFR, cMET, and VEGF pathways are frequently observed together in these malignanc...

(This article belongs to the Topic Antibody-Mediated Therapy and Other Emerging Therapies in Cancer Treatment)
  • Article
  • Open Access
228 Views
31 Pages

22 October 2026

Background/Objectives: Mammalian display enables direct screening of full-length IgG antibodies, but genetically controlled library construction remains technically demanding. Here, we developed a mammalian display platform in which a target-naï...

(This article belongs to the Section Antibody Discovery and Engineering)
  • Article
  • Open Access
178 Views
13 Pages

Purification of Bioactive Natural Antibodies to PD-1 Known as Regulatory Rheumatoid Factor from Human Blood Plasma

  • Daria Menshikova,
  • Alexey Terentiev,
  • Pavel Ivanov,
  • Alexandr Cherednichenko and
  • Liubov Beduleva

19 October 2026

Background/Objectives: Regulatory rheumatoid factor (regRF) is a recently discovered population of natural anti-idiotypic antibodies carrying a shared paratope specific to the PD-1 molecule. Normally, regRF exerts a cytotoxic effect on PD-1-expressin...

(This article belongs to the Section Antibody Discovery and Engineering)
  • Article
  • Open Access
222 Views
19 Pages

Long-Term Changes in Complete Blood Count-Derived Inflammatory Indices During Risankizumab Treatment for Psoriasis: A 208-Week Multicenter Real-World Study

  • Riccardo Balestri,
  • Chiara Pallanch,
  • Michela Magnano,
  • Jacopo Colombini and ,
  • Giacomo Clarizio,
  • Federico Bardazzi,
  • Vito Di Lernia,
  • Francesca Satolli,
  • Giulia Ganzetti and
  • Francesco Bellinato
  • + 16 authors+ 11 authors

14 October 2026

Background/Objectives: Blood count-derived inflammatory indices have been proposed as accessible biomarkers of systemic inflammation in psoriasis, but their longitudinal behavior during selective interleukin-23 blockade remains uncertain. We evaluate...

(This article belongs to the Section Antibody-Based Therapeutics)
  • Review
  • Open Access
308 Views
39 Pages

12 October 2026

Primary mesangial proliferative glomerulonephritis (MesPGN) refers to the light microscopic description of increased mesangial cells (greater than three cells per mesangial area) without endocapillary proliferation, necrosis, and crescents in the abs...

(This article belongs to the Section Humoral Immunity)
  • Systematic Review
  • Open Access
259 Views
44 Pages

Switching Beyond Rituximab in Primary Glomerular Diseases: A Systematic Review of Within-Patient Efficacy and Safety of Non-Rituximab Anti-CD20 Antibodies

  • Francesca K. Martino,
  • Lucia F. Stefanelli,
  • Leda Cattarin,
  • Dorella Del Prete and ,
  • Anna Basso and
  • Federico Nalesso
  • + 1 author+ 0 author

10 October 2026

Background/Objectives: Rituximab is widely used in primary glomerular diseases, but treatment may fail for several reasons, including primary non-response, incomplete response, relapse, intolerance or anti-rituximab antibodies. We assessed within-pat...

(This article belongs to the Section Antibody-Based Therapeutics)
  • Review
  • Open Access
329 Views
25 Pages

Antibody-Related Mechanisms in Ocular Diseases: Autoimmunity, Malignancy, and Therapeutic Targeting

  • Yehan Xiao,
  • Yaru Zou,
  • Mingming Yang,
  • Wendong Gu and ,
  • Zizhen Ye,
  • Jiaxin Deng,
  • Kyoko Ohno-Matsui and
  • Koju Kamoi
  • + 3 authors+ 0 author

8 October 2026

Antibodies in ocular disease have heterogeneous biological meanings: they may act as direct pathogenic effectors, systemic diagnostic biomarkers, indicators of B-cell clonality, or therapeutic agents. This distinction is particularly important in the...

(This article belongs to the Section Humoral Immunity)
  • Article
  • Open Access
381 Views
18 Pages

Head-to-Head Comparison of FAP Antibody Clones for Tissue Expression Analysis

  • Elena Shmakova,
  • Anna Kalinchuk,
  • Elisaveta Tsarenkova,
  • Pavel Bazhenov and ,
  • Vlada Vasilchuk,
  • Dmitry Loos and
  • Liubov Tashireva
  • + 2 authors+ 0 author

8 October 2026

Background: Fibroblast activation protein (FAP) is a promising target for cancer diagnosis and therapy, but the specificity and sensitivity of anti-FAP antibodies used for immunohistochemistry (IHC) vary considerably. A head-to-head comparison of com...

(This article belongs to the Section Antibody-Based Diagnostics)
  • Article
  • Open Access
582 Views
20 Pages

Targeting the Complement C1 Proteases Using Camelid-Derived Single Domain Antibodies: Production, Characterization and Possible Application for Tissue/Fluid Analysis

  • Nolwenn Haut,
  • Véronique Rossi,
  • Julie Peliconi,
  • Jean-Baptiste Reiser and ,
  • Nicole M. Thielens,
  • Lubka T. Roumenina and
  • Christine Gaboriaud
  • + 2 authors+ 0 author

5 October 2026

Background. The complement C1r and C1s proteases initiate the classical complement pathway within the C1 complex, but emerging evidence points to additional roles in tissues, including cell-intrinsic functions linked to cancer and connective tissue d...

(This article belongs to the Section Antibody Discovery and Engineering)
  • Review
  • Open Access
375 Views
18 Pages

Complement in HER2-Positive Breast Cancer: A Conditionally Protective Mechanism Under Attack

  • Dobromira Petkova,
  • Ivaila Kuleva,
  • Zhasmin Stoyanova,
  • Boryana Ilcheva and ,
  • Albena Fakirova,
  • Zhasmina Mihaylova and
  • Maria Radanova
  • + 2 authors+ 0 author

5 October 2026

The therapeutic efficacy of anti-HER2 monoclonal antibodies in breast cancer has traditionally been attributed to direct inhibition of signaling and antibody-dependent cellular cytotoxicity (ADCC). Recent evidence, however, has established complement...

(This article belongs to the Section Antibody-Based Therapeutics)
  • Review
  • Open Access
300 Views
19 Pages

5 October 2026

Spondyloarthritis is a multi-faceted condition housing a group of inter-related chronic inflammatory rheumatic diseases such as ankylosing spondylitis, IBD-associated arthritis, psoriatic arthritis and juvenile idiopathic arthritis. While decades of...

(This article belongs to the Section Antibody-Based Therapeutics)
  • Article
  • Open Access
456 Views
25 Pages

Development and Validation of Novel VHHs Targeting Astrocyte-Enriched Glutamate Transporters GLT-1 and GLAST-1

  • Noelia Gesteira-Pérez,
  • Pieterjan Van Maele,
  • Benedetta Frizzi,
  • Ludo Van Den Bosch and ,
  • Laura Rué and
  • Maarten Dewilde
  • + 1 author+ 0 author

29 September 2026

Background/Objectives. VHHs (Nanobodies®) are camelid single-domain antibody fragments with broad applicability in central nervous system (CNS) research, including blood–brain barrier transport, modulation of pathological proteins and molec...

(This article belongs to the Section Antibody Discovery and Engineering)
  • Review
  • Open Access
655 Views
20 Pages

Targeted Therapy for Antihistamine-Refractory Chronic Spontaneous Urticaria: A Critical Narrative Review and an Evidence-Graded Approach to Agent Selection

  • Luca Guarino,
  • Giuseppe Rizzuto,
  • Vincenzo Coppolelli,
  • Alessia Scipione and ,
  • Mirella Scattone,
  • Luca Gargano,
  • Pietro Scribani Rossi,
  • Ester Del Duca,
  • Annunziata Dattola and
  • Camilla Chello
  • + 7 authors+ 2 authors

17 September 2026

Background/Objectives: Chronic spontaneous urticaria (CSU) is a mast-cell-driven disease with autoimmune mechanisms and an incompletely clarified aetiology, in which a substantial proportion of patients remain symptomatic despite second-generation H1...

(This article belongs to the Section Antibody-Based Therapeutics)
  • Review
  • Open Access
563 Views
31 Pages

17 September 2026

Cancer progression and therapeutic resistance are shaped by reciprocal dynamic interactions between malignant cells and the metabolically altered tumor microenvironment (TME). Tumor-associated hypoxia, glucose and amino acid competition, extracellula...

(This article belongs to the Special Issue Unravelling Effector Functions of B cells in Infectious Diseases and Cancer)
  • Review
  • Open Access
601 Views
25 Pages

Antibody-Based Biologics for CNS Disorders

  • Eric Ka-Wai Hui and
  • Ruben J. Boado

16 September 2026

The blood-brain barrier (BBB) is permeable only to small lipophilic molecules, whereas hydrophilic nutrients, such as glucose and amino acids, cross the BBB via carrier-mediated transport systems. In contrast, circulating proteins do not cross the BB...

(This article belongs to the Section Antibody-Based Therapeutics)
  • Article
  • Open Access
898 Views
16 Pages

Prevalence and Clinical Associations of Systemic Sclerosis-Related Autoantibodies: A Nationwide Reuma.pt Cohort Study

  • Carolina Mazeda,
  • Eduardo Dourado,
  • Raquel Freitas,
  • Patrícia Martins and ,
  • Liliana Saraiva,
  • Tânia Santiago,
  • Francisca Guimarães,
  • Emanuel Costa,
  • Diogo Esperança Almeida and
  • Inês Cordeiro
  • + 17 authors+ 12 authors

15 September 2026

Background: Autoantibodies are central to the diagnosis and risk stratification of systemic sclerosis (SSc), but their prevalence and clinical associations may vary across populations. This study aimed to evaluate the prevalence and immuno-clinical a...

(This article belongs to the Section Antibody-Based Diagnostics)
  • Review
  • Open Access
802 Views
66 Pages

Molecular Architecture and Clinical Landscape of Immune Checkpoint Receptors and Ligands

  • Milena Czosnek,
  • Agata Sowa,
  • Łucja Rolek,
  • Ewelina Grywalska and ,
  • Sebastian Mertowski and
  • Paulina Mertowska
  • + 1 author+ 0 author

9 September 2026

Immune checkpoints (ICPs) are essential regulators of immune homeostasis, maintaining the balance between effective immune responses and tolerance to self-antigens. Dysregulation of ICP signaling may contribute to impaired immune surveillance, immune...

(This article belongs to the Special Issue Overcoming Resistance to Immune Checkpoint Blockade: Mechanisms and Novel Therapeutics)
  • Article
  • Open Access
521 Views
18 Pages

7 September 2026

Background/Objectives: Cadherin-16 (CDH16, Ksp-cadherin) possesses unique seven extracellular cadherin repeats, and its expression is restricted to normal kidney epithelium. CDH16 is downregulated in renal cell carcinoma (RCC) and is associated with...

(This article belongs to the Section Antibody Discovery and Engineering)
  • Article
  • Open Access
788 Views
14 Pages

Seroprevalence of IgG Antibodies to Measles, Mumps, Rubella and Varicella in Adolescents with Documented Two-Dose MMR Vaccination: Cross-Sectional Study

  • Mikhail P. Kostinov,
  • Ivan S. Samolygo,
  • Aristitsa M. Kostinova,
  • Natalya L. Starikova and ,
  • Marina A. Manina,
  • Valentina B. Polishchuk,
  • Albina S. Pestova,
  • Pavel I. Zhuravlev,
  • Anton S. Antishin and
  • Svetlana I. Erdes
  • + 5 authors+ 0 author

4 September 2026

Background: Measles, mumps, and rubella outbreaks continue to occur despite high vaccination coverage, raising concerns about long-term vaccine-induced immunity. This study assessed serological protection against measles, mumps, rubella, and varicell...

(This article belongs to the Special Issue Antiviral Antibody Immune Responses in the Context of Vaccination and Infection)
  • Review
  • Open Access
1,447 Views
34 Pages

2 September 2026

Background/Objectives: Artificial intelligence (AI) has transformed computational antibody engineering by enabling accurate prediction of antibody structures, rational optimization of therapeutic properties, and de novo antibody design. Recent advanc...

(This article belongs to the Section Antibody Discovery and Engineering)
  • Review
  • Open Access
1,519 Views
28 Pages

Advances in Bispecific Antibodies and Antibody–Drug Conjugates for Colorectal Cancer Treatment

  • Maya G. Cappellino,
  • Sean P. Sullivan,
  • Peyton C. High,
  • Tiffani A. Blackburn and
  • Kendra S. Carmon

1 September 2026

Bispecific antibodies (bsAbs) and bispecific antibody–drug conjugates (bsADCs) represent promising classes of emerging targeted therapeutics with the potential to overcome tumor heterogeneity and resistance in colorectal cancer (CRC). BsAbs can...

(This article belongs to the Section Antibody-Based Therapeutics)
  • Article
  • Open Access
619 Views
17 Pages

Clinical Characteristics and Risk Factors for Severe Immune-Related Liver Injury Following Nivolumab and Ipilimumab Combination Therapy

  • Yuichi Yamazaki,
  • Satoru Kakizaki,
  • Yuki Tamura,
  • Yumeo Tateyama and ,
  • Tatsuma Murakami,
  • Takuya Adachi,
  • Hiroki Tojima and
  • Toshio Uraoka
  • + 3 authors+ 0 author

1 September 2026

Background: Combination therapy with nivolumab and ipilimumab (Nivo-Ipi) has substantially improved outcomes in several advanced malignancies but is frequently associated with early-onset, severe immune-related liver injury (irAE-LI). This study aime...

(This article belongs to the Topic Antibody-Mediated Therapy and Other Emerging Therapies in Cancer Treatment)
  • Editorial
  • Open Access
352 Views
4 Pages

1 September 2026

Antibody therapeutics now span across oncology, infectious disease, and autoimmunity, and the molecules entering development are increasingly being engineered rather than merely selected [...]

(This article belongs to the Special Issue A Festschrift Celebrating Dr. Dimiter Stanchev Dimitrov: Antibodies, Innovation, and Impact on Infectious Disease and Cancer Research)
  • Article
  • Open Access
1,054 Views
19 Pages

12 August 2026

GNR-068 is a proposed biosimilar to the ustekinumab reference product (RP), which works through the antagonism of interleukin 12 and interleukin 23. Ustekinumab RP is used for the treatment of chronic inflammatory conditions, including certain forms...

(This article belongs to the Special Issue Immune Phenomena in Autoimmune Skin Disorders)
  • Article
  • Open Access
984 Views
18 Pages

A CSF-1R Ig4-5 Domain-Targeting Antibody for the Treatment of Idiopathic Pulmonary Fibrosis

  • Wusong Luo,
  • Zhe Shao,
  • Tao Wang,
  • Kenghoe Lok and ,
  • Rongjing Zhang and
  • Yao Li
  • + 1 author+ 0 author

11 August 2026

Background: Idiopathic pulmonary fibrosis (IPF) is closely associated with fibroblast proliferation, macrophage polarization, and the accumulation of extracellular matrix (ECM). Targeting CSF-1R can rebalance macrophages, reduce ECM deposition, and b...

(This article belongs to the Section Antibody-Based Therapeutics)
  • Review
  • Open Access
1,463 Views
21 Pages

Advances in the Development of a Universal Influenza Vaccine

  • Preanka Mudaly,
  • Max Lee,
  • Aishwarya Bhatta and
  • Craig Thompson

11 August 2026

Influenza remains a persistent global health threat, accounting for an estimated one billion infections and 350,000–600,000 deaths worldwide annually. Beyond substantial mortality and morbidity, influenza imposes major socio-economic costs thro...

(This article belongs to the Section Antibody-Based Therapeutics)
  • Article
  • Open Access
672 Views
13 Pages

11 August 2026

Background: Ocular myasthenia gravis (OMG) can remain restricted to ocular symptoms or progress to generalized myasthenia gravis (GMG). However, the rate of generalization and its predictors may vary across populations, and data on South Korean patie...

(This article belongs to the Section Antibody-Based Diagnostics)
  • Article
  • Open Access
914 Views
12 Pages

Real-World Effectiveness of Secukinumab in Congenital Ichthyoses: A Retrospective Monocentric Case Series

  • Orsola Crespi,
  • Umberto Santaniello,
  • Luca Cangialosi,
  • Ambra Bonvicino and ,
  • Michela Ortoncelli,
  • Francois Rosset,
  • Luca Mastorino,
  • Simone Ribero and
  • Pietro Quaglino
  • + 4 authors+ 0 author

11 August 2026

Background/Objectives: Congenital ichthyoses (CI) are inherited disorders of keratinization characterized by epidermal barrier dysfunction, abnormal desquamation, and variable degrees of inflammation. Increasing evidence suggests a role for IL-23/Th1...

(This article belongs to the Section Antibody-Based Therapeutics)
  • Article
  • Open Access
900 Views
13 Pages

7 August 2026

Background: Sex-related differences in SARS-CoV-2 viral susceptibility, severity, and recovery are prevalent. Factors such as age and biological variation provide some explanation for immune response, yet the use of biological sex as a variable may l...

(This article belongs to the Special Issue Antiviral Antibody Immune Responses in the Context of Vaccination and Infection)
  • Review
  • Open Access
1,309 Views
9 Pages

6 August 2026

Inflammatory bowel diseases (IBDs), chronic inflammatory disorders of the gastrointestinal tract, are classified into Crohn’s disease (CD) and ulcerative colitis (UC). Despite differing clinical manifestations, both CD and UC share a common imm...

(This article belongs to the Section Antibody-Based Therapeutics)
  • Review
  • Open Access
1,460 Views
18 Pages

6 August 2026

Sickle cell disease (SCD) represents one of the most complex hematological diseases leading to a lifetime of physiological crises characterized by chronic hemolysis, inflammation, hypoxia, and anemia with changes to body systems that result in patien...

(This article belongs to the Section Humoral Immunity)
  • Review
  • Open Access
1,122 Views
19 Pages

Bispecific Antibodies for Acute Myeloid Leukemia: From Bone Marrow Immune Niche to Clinical Translation

  • Antonella Bruzzese,
  • Enrica Antonia Martino,
  • Santino Caserta,
  • Maria Eugenia Alvaro and ,
  • Nicola Amodio,
  • Eugenio Lucia,
  • Virginia Olivito,
  • Caterina Labanca,
  • Francesco Mendicino and
  • Massimo Gentile
  • + 7 authors+ 2 authors

4 August 2026

Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy characterized by the clonal expansion of myeloid blasts and the persistence of leukemic stem cells (LSCs) within a profoundly remodeled bone marrow (BM) microenvironment. Despite...

(This article belongs to the Section Antibody-Based Therapeutics)
  • Article
  • Open Access
664 Views
21 Pages

4 August 2026

Background/Objectives: Aryl hydrocarbon receptor (AHR) ligands are known to suppress antibody production. However, it remains unclear whether this suppression translates into altered antibody-mediated Fcγ receptor signaling in human cells. This...

(This article belongs to the Section Humoral Immunity)
  • Review
  • Open Access
1,576 Views
24 Pages

Functional Parameters of Hybridoma Cells: Methods of Evaluation and Biotechnological Relevance

  • Tatiana Bezukladnikova,
  • Svetlana Zamorina,
  • Sergey Lazarev and
  • Mikhail Rayev

4 August 2026

Hybridoma technology remains one of the most reliable and widely used platforms for generating highly specific monoclonal antibodies for use in diagnostics, fundamental research, and clinical practice. Moreover, the combination of unlimited prolifera...

(This article belongs to the Section Antibody Discovery and Engineering)
  • Article
  • Open Access
4,161 Views
14 Pages

Fc-Silenced CD89 × EGFR Bispecific Antibodies Promote Neutrophil and Macrophage Antitumor Activity

  • Felix Meiser,
  • Julia Harwardt,
  • Christoph Hahn,
  • Marta Lustig and ,
  • Thomas Valerius and
  • Harald Kolmar
  • + 1 author+ 0 author

Background/Objectives: CD89 (FcaRI), the receptor for immunoglobulin A (IgA), is expressed on myeloid cells, including neutrophils, monocytes, and macrophages. It is known to mediate potent effector functions against tumor cells, but the clinical dev...

(This article belongs to the Section Antibody Discovery and Engineering)
  • Article
  • Open Access
931 Views
18 Pages

Biopsy-Confirmed Acute Interstitial Nephritis in Patients Treated with Immune Checkpoint Inhibitors: A Single-Center Retrospective Case Series

  • Ioannis Ogrotis,
  • Konstantinos Drouzas,
  • Evangelia Pantzopoulou,
  • Petros Nikolopoulos and ,
  • Ioannis Kotsantis,
  • Amanda Psyrri,
  • George Liapis and
  • Sophia Lionaki
  • + 3 authors+ 0 author

Background/Objectives: Acute interstitial nephritis (AIN) is a cause of acute kidney injury (AKI) during immune checkpoint inhibitor (ICI) therapy, but biopsy-confirmed data are limited. We estimated institutional proportions of biopsy-confirmed AIN...

(This article belongs to the Section Antibody-Based Therapeutics)
  • Article
  • Open Access
764 Views
13 Pages

Background: The elicitation of broadly neutralizing antibodies against conserved antigenic epitopes has been a focus of universal vaccine research. To facilitate immunofocusing on the conserved influenza hemagglutinin (HA) stalk, we designed headless...

(This article belongs to the Section Humoral Immunity)
  • Review
  • Open Access
2,409 Views
27 Pages

Although mAbs have great therapeutic potential, their use in medicine is currently limited by the high cost of their manufacturing. Significant developments in upstream processing technologies have caused downstream processing (DSP) to become the man...

(This article belongs to the Section Antibody-Based Therapeutics)
  • Article
  • Open Access
593 Views
14 Pages

Sera of Healthy First-Degree Relatives of SLE Patients Contain Autoantibodies to Globular Domains of C1q

  • Ginka Cholakova,
  • Alexandra Atanasova,
  • Alexandra Kapogianni,
  • Dobroslav Kyurkchiev and ,
  • Bogdan Penev and
  • Ivanka Tsacheva
  • + 1 author+ 0 author

Background/Objectives: The autoimmune disorder Systemic Lupus Erythematosus (SLE) is characterized by increased titers of autoantibodies with different specificities against autoantigens, including the complement proteins C1q, C3 and Factor H. SLE is...

(This article belongs to the Special Issue Antibody and Autoantibody Specificities in Autoimmunity)
  • Review
  • Open Access
1,355 Views
22 Pages

Natural Versus Vaccine-Induced Immunity Against HPV: A Comparative Review of Antibody Response and Cancer Prevention

  • Bogdan Ghilencea,
  • Bianca Ilinca Moroianu,
  • Ancuța-Iuliana Năstac,
  • Ioana-Stefania Bostan and ,
  • Anca Panaitescu,
  • Claudia Mehedințu and
  • Nicolae Gică
  • + 2 authors+ 0 author

Human Papillomavirus (HPV) infection is the leading cause of cervical cancer, presenting a significant global health challenge. While natural infection is widespread, the resulting immune response is often characterized by weak, delayed, and type-spe...

(This article belongs to the Section Humoral Immunity)
  • Review
  • Open Access
1,542 Views
13 Pages

The Diagnostic and Clinical Significance of Anti-Mutated Citrullinated Vimentin Antibodies in Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Scoping Review

  • Christian D’Elia,
  • Giada Santagata,
  • Serena Guiducci,
  • Holger Bang and ,
  • Mariangela Manfredi,
  • Maria Infantino and
  • Maurizio Benucci
  • + 2 authors+ 0 author

Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) is one of the most severe extra-articular manifestations of rheumatoid arthritis (RA), requiring reliable biomarkers for early detection. This scoping review synthesized current evide...

(This article belongs to the Section Antibody-Based Diagnostics)
  • Article
  • Open Access
1 Citations
1,460 Views
20 Pages

A Novel Anti-Cadherin-17 Monoclonal Antibody, Ca17Mab-5, for Multiple Applications

  • Reina Ito,
  • Hiroyuki Suzuki,
  • Kenichiro Ishikawa,
  • Kazutake Yagi and ,
  • Akira Ohkoshi,
  • Yukio Katori,
  • Mika K. Kaneko and
  • Yukinari Kato
  • + 3 authors+ 0 author

Background/Objectives: Cadherin-17 (CDH17, LI-cadherin) is a non-classical cadherin with an atypical structure and unique functions. CDH17 expression is restricted to normal intestinal epithelium. Furthermore, CDH17 functions as an oncoprotein that p...

(This article belongs to the Special Issue Therapeutic Antibodies: New Trends in Discovery, Developability and Characterization)
  • Article
  • Open Access
1,150 Views
13 Pages

Background: Antinuclear antibodies (ANA) can be detected in patients with rheumatoid arthritis (RA) and pose many diagnostic challenges, especially when RA presents an atypical course and requires differentiation from other systemic connective tissue...

(This article belongs to the Section Antibody-Based Diagnostics)
  • Review
  • Open Access
1 Citations
1,249 Views
13 Pages

Daratumumab, a human IgG1 monoclonal antibody targeting CD38, is widely used in multiple myeloma and AL amyloidosis. Despite its clinical success, many patients fail to achieve durable responses or relapse, underscoring the importance of understandin...

(This article belongs to the Topic Antibody-Mediated Therapy and Other Emerging Therapies in Cancer Treatment)
  • Article
  • Open Access
1,241 Views
13 Pages

Phage-Selected Clickable Gln-Donor Peptide for Lys-Selective Fab Labeling Using Engineered Microbial Transglutaminase

  • Eva Agustriana,
  • Koki Murozono,
  • Kosuke Minamihata,
  • Riko Nishioka and
  • Noriho Kamiya

Background/Objectives: The use of cross-linking enzymes for site-selective and efficient antibody modification has attracted considerable attention. Microbial transglutaminase (MTG)-mediated labeling of IgG at Gln295 has emerged as a promising strate...

(This article belongs to the Section Antibody Discovery and Engineering)
  • Review
  • Open Access
1,875 Views
17 Pages

Immune-mediated neutropenias comprise a heterogeneous group of disorders characterized by antibody-mediated destruction of neutrophils, in which the detection of anti-neutrophil antibodies remains a significant diagnostic challenge. Human neutrophil...

(This article belongs to the Section Antibody-Based Diagnostics)
XFacebookLinkedIn
Antibodies - ISSN 2073-4468